Are risk factors for non-alcoholic fatty liver disease (NAFLD) important in determining hepatitis C virus (HCV) recurrence and severity in patients undergoing liver transplantation (LT)?

被引：0
|
作者：
Weston, SR
Ruppert, K
Bell, SH
Everhart, JF
Charlton, MR
Weisner, RH
Schafer, D
Detre, K
Roberts, JP
Bass, NM
Terrault, NA
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] NIDDK, Bethesda, MD USA
[4] Mayo Clin, Rochester, MN USA
[5] Univ Nebraska, Omaha, NE 68182 USA
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
61
引用
收藏
页码：182A / 182A
页数：1
相关论文
共 50 条
  • [41] Non-Alcoholic Fatty Liver Disease (NAFLD) Epidemic and Its Implications for Liver Transplantation.
    Kemmer, N.
    Neff, G.
    Parkinson, E.
    Cece, E.
    Alsina, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 223 - 224
  • [42] Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)
    Yoneda, M.
    Fujita, K.
    Inamori, M.
    Nakajima, A.
    Yoneda, M.
    Tamano, M.
    Hiraishi, H.
    GUT, 2007, 56 (09) : 1330 - 1331
  • [43] Are there risk factors other than genotype associated to hepatitis C virus (HCV) recurrence after liver transplantation (LT)?
    Pageaux, GP
    Parolini, I
    Duvoux, C
    Vanlemmens, C
    Picot, MC
    Cherqui, D
    Dhumeaux, C
    Mantion, G
    Miguet, JP
    Domergue, J
    Larrey, D
    JOURNAL OF HEPATOLOGY, 2000, 32 : 60 - 60
  • [44] Are there risk factors other than genotype associated to hepatitis C virus (HCV) recurrence after liver transplantation (LT)?
    Parolini, I
    Pageaux, GP
    Duvoux, C
    Vanlemmens, C
    Picot, MC
    Cherqui, D
    Dhumeaux, D
    Mantion, DD
    Miguet, JP
    Domergue, J
    Larrey, D
    GASTROENTEROLOGY, 2000, 118 (04) : A1478 - A1478
  • [45] Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern?
    Armstrong, Matthew J.
    Haydon, Geoffrey
    Syn, Wing-Kin
    HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (02) : 138 - 142
  • [46] Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    Tasneem, Abbas Ali
    Luck, Nasir Hassan
    Majid, Zain
    TROPICAL DOCTOR, 2018, 48 (02) : 107 - 112
  • [47] A multidisciplinary approach to non-alcoholic fatty liver disease (NAFLD) improves cardiovascular risk factors
    Mantovani, Anna
    Goyale, Atul
    Roccarina, Davide
    Prat, Laura Iogna
    Guerrero, Marta
    Patel, Roshni
    Clancy, Jennifer
    Nair, Devaki
    Tsochatzis, Emmanuel
    JOURNAL OF HEPATOLOGY, 2020, 73 : S110 - S110
  • [48] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [49] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS RELATED TO NON-ALCOHOLIC FATTY PANCREAS DISEASE (NAFPD)
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C.
    Bloemena, Elisabeth
    van der Peet, Donald L.
    Mulder, Chris J.
    HEPATOLOGY, 2009, 50 (04) : 788A - 788A
  • [50] MOLECULAR PROFILING OF THE LIVER TRANSCRIPTOME: CHANGES ASSOCIATED WITH SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Shea, Patrick
    Mehta, Sanket
    Farrell, Ava
    Destin, Brittney
    Remotti, Helen
    Bessler, Marc
    Krikhely, Abraham
    Reilly, Muredach P.
    Anyanwu-Ofili, Anuli
    Rajagopal, Gunaretnam
    Wattacheril, Julia J.
    HEPATOLOGY, 2021, 74 : 347A - 348A
12345